Givinostat for treating Duchenne muscular dystrophy in people 6 years and over

Evaluation committee members

This topic was evaluated as a single technology evaluation by the highly specialised technologies evaluation committee. Because of this, some members of the technology evaluation committees were brought in to provide additional expertise to the committee. The highly specialised technologies evaluation committee and the 4 technology evaluation committees are standing advisory committees of NICE.

Committee members are asked to declare any interests in the technology being evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

The minutes of each evaluation committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.